Fibrobiologics Inc (FBLG)

Apr 29, 2025

FibroBiologics Presents at the ThymUS 2025 Meeting - GlobeNewswire

Apr 29, 2025

Apr 29, 2025

FibroBiologics Research Scientist Presents Innovative Thymus Organoid Development at ThymUS 2025 Meeting - Nasdaq

Apr 29, 2025

Apr 29, 2025

Revolutionary Thymus Organoid Breakthrough: FibroBiologics Reveals New T-Cell Generation Method - Stock Titan

Apr 29, 2025

Apr 26, 2025

FibroBiologics, Inc. (NASDAQ:FBLG) Shares Acquired by Cerity Partners LLC - Defense World

Apr 26, 2025

Apr 22, 2025

FibroBiologics Inc Inc. (FBLG) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 22, 2025

Apr 15, 2025

O Shaughnessy Asset Management LLC Acquires New Position in FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Apr 15, 2025

Apr 14, 2025

Raymond James Financial Inc. Invests $37,000 in FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Apr 14, 2025

Apr 12, 2025

FibroBiologics’ (FBLG) Buy Rating Reiterated at D. Boral Capital - Defense World

Apr 12, 2025

Apr 11, 2025

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean - GlobeNewswire

Apr 11, 2025

Apr 11, 2025

Revolutionary Cell Therapy: FibroBiologics Unveils Multi-Disease Treatment Platform in Rome - Stock Titan

Apr 11, 2025

Apr 10, 2025

Houston Biotechnology Company Brings Manufacturing Ops Home With New Facility - Bisnow

Apr 10, 2025

Apr 09, 2025

Fibrobiologics stock plunges to 52-week low at $0.8 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025

Apr 09, 2025

Fibrobiologics stock plunges to 52-week low at $0.8 amid market challenges - Investing.com India

Apr 09, 2025

Apr 09, 2025

FibroBiologics opens cell therapy manufacturing space ahead of clinical trials - The Business Journals

Apr 09, 2025

Apr 09, 2025

OTC Markets Hosts Virtual Investor Presentation with Pete O'Heeron, CEO & Chairman of FibroBiologics, Inc., with David Bautz, PhD, Senior Analyst at Zacks SCR - Yahoo Finance

Apr 09, 2025

Apr 08, 2025

FibroBiologics opens new lab to boost chronic disease research By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

FibroBiologics opens new lab to boost chronic disease research - Investing.com

Apr 08, 2025

Apr 08, 2025

FibroBiologics announces opening of new lab facility - TipRanks

Apr 08, 2025

Apr 08, 2025

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics - The Manila Times

Apr 08, 2025

Apr 08, 2025

FibroBiologics Unveils New and Expanded Houston Laboratory - GlobeNewswire

Apr 08, 2025

Apr 08, 2025

FibroBiologics Supercharges R&D with Massive New Lab Launch: In-House Manufacturing Next - Stock Titan

Apr 08, 2025

Apr 07, 2025

Zacks Small Cap Weighs in on FibroBiologics Q1 Earnings - Defense World

Apr 07, 2025

Apr 04, 2025

FY2025 EPS Estimates for FibroBiologics Increased by Analyst - Defense World

Apr 04, 2025

Apr 03, 2025

FBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25… - Zacks Small Cap Research

Apr 03, 2025

Apr 03, 2025

HC Wainwright Comments on FibroBiologics Q1 Earnings - Defense World

Apr 03, 2025

Apr 02, 2025

FibroBiologics gibt wissenschaftlicher Fortschritte bei der Reparatur von Hirngewebe bekannt - GlobeNewswire Inc.

Apr 02, 2025

Apr 02, 2025

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair - GlobeNewswire

Apr 02, 2025

Apr 02, 2025

FibroBiologics announces advancement in results of brain tissue repair - TipRanks

Apr 02, 2025

Apr 02, 2025

Fibrobiologics Announces Scientific Advancement In Confirmation Results Of Brain Tissue Repair - MarketScreener

Apr 02, 2025

Apr 02, 2025

Major Breakthrough: FibroBiologics Confirms Brain Tissue Regeneration Success - Stock Titan

Apr 02, 2025

Apr 02, 2025

FibroBiologics’ (FBLG) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World

Apr 02, 2025

Apr 02, 2025

Virtu Financial LLC Buys New Holdings in FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Apr 02, 2025

Apr 02, 2025

FibroBiologics’ (FBLG) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Apr 02, 2025

Mar 31, 2025

Fibrobiologics stock plunges to 52-week low at $0.93 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Fibrobiologics stock plunges to 52-week low at $0.93 amid market challenges - Investing.com Canada

Mar 31, 2025

Mar 31, 2025

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update - The Manila Times

Mar 31, 2025

Mar 31, 2025

FibroBiologics Slashes Annual Losses by $5.3M as Key Clinical Trial Approaches - Stock Titan

Mar 31, 2025

Mar 28, 2025

Spotting Winners: TopBuild (NYSE:BLD) And Home Builders Stocks In Q4 - The Globe and Mail

Mar 28, 2025

Mar 27, 2025

FibroBiologics Announces 2025 Annual Meeting of Stockholders - GlobeNewswire

Mar 27, 2025

Mar 27, 2025

Biotech Pioneer FibroBiologics Reveals Massive 160+ Patent Portfolio at Upcoming Shareholder Meeting - Stock Titan

Mar 27, 2025

Mar 27, 2025

Applied Industrial (AIT): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail

Mar 27, 2025

Mar 26, 2025

3 Reasons to Avoid FUBO and 1 Stock to Buy Instead - The Globe and Mail

Mar 26, 2025

Mar 25, 2025

Intuitive Machines Stock (LUNR) Lifts Off with 30% Surge Post Q4 Results - The Globe and Mail

Mar 25, 2025

Mar 21, 2025

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting - GlobeNewswire

Mar 21, 2025

Mar 21, 2025

FibroBiologics Announces Presentation on Innovative Fibroblast-Based Therapeutics at The German-Nordic Joint Extracellular Matrix Meeting - Nasdaq

Mar 21, 2025

Mar 18, 2025

FBLG stock touches 52-week low at $0.98 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 18, 2025

Mar 18, 2025

FBLG stock touches 52-week low at $0.98 amid sharp annual decline - Investing.com Australia

Mar 18, 2025